tiprankstipranks
Sinopharm Group Co Ltd Class H (HK:1099)
:1099
Hong Kong Market
1099
Sinopharm Group Co
RESEARCH TOOLSreports
Want to see HK:1099 full AI Analyst Report?

Sinopharm Group Co (1099) Financial Statements

10 Followers

Sinopharm Group Co Financial Overview

Sinopharm Group Co's market cap is currently HK$58.61B. The company's EPS TTM is HK$0.5156222085000001; its P/E ratio is 7.82; and it has a dividend yield of 3.75%. Sinopharm Group Co is scheduled to report earnings on April 27, 2026, and the estimated EPS forecast is HK$1.25. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 560.28B¥ 584.51B¥ 596.57B¥ 552.15B¥ 521.05B
Gross Profit¥ 40.15B¥ 44.26B¥ 48.51B¥ 47.43B¥ 44.05B
Operating Income¥ 16.24B¥ 16.19B¥ 20.21B¥ 20.60B¥ 19.71B
EBITDA¥ 20.41B¥ 20.17B¥ 26.90B¥ 26.25B¥ 24.68B
Net Income¥ 6.97B¥ 7.05B¥ 9.05B¥ 8.53B¥ 7.76B
Balance Sheet
Cash & Short-Term Investments¥ 61.59B¥ 54.31B¥ 63.81B¥ 55.22B¥ 43.54B
Total Assets¥ 390.53B¥ 392.83B¥ 383.39B¥ 364.78B¥ 335.41B
Total Debt¥ 108.63B¥ 76.39B¥ 73.78B¥ 69.59B¥ 68.37B
Net Debt¥ 47.04B¥ 22.07B¥ 9.97B¥ 14.37B¥ 24.84B
Total Liabilities¥ 256.31B¥ 266.14B¥ 263.08B¥ 254.71B¥ 235.76B
Stockholders' Equity¥ 83.99B¥ 78.88B¥ 74.58B¥ 68.07B¥ 61.89B
Cash Flow
Free Cash Flow¥ 12.52B¥ 9.58B¥ 14.84B¥ 18.55B¥ 7.05B
Operating Cash Flow¥ 14.14B¥ 11.55B¥ 17.17B¥ 20.96B¥ 9.31B
Investing Cash Flow¥ -963.89M¥ -3.75B¥ -944.53M¥ -3.59B¥ -1.27B
Financing Cash Flow¥ -18.69B¥ -17.29B¥ -7.64B¥ -5.69B¥ -14.69B
Currency in CNY

Sinopharm Group Co Earnings and Revenue History

Income Statement >

Sinopharm Group Co Debt to Assets

Balance Sheet >

Sinopharm Group Co Cash Flow

Cash Flow >

Sinopharm Group Co Forecast EPS vs Actual EPS

Earnings >